Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMY-25271 is an antagonist of histamine H2 receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BMY-25271 is an antagonist of histamine H2 receptor. |
In vivo | The dose-response curves are parallel and oral ED50 values derived from probit analysis are 0.093, 0.97, and 6.9 mg/kg for BMY-25271, ranitidine, and cimetidine, respectively. BMY-25271 is about 10 and 74 times more potent than ranitidine and cimetidine, respectively. |
Molecular Weight | 329.44 |
Formula | C12H19N5O2S2 |
CAS No. | 78441-82-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMY-25271 78441-82-4 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor BMY 25271 BMY25271 inhibitor inhibit